This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sansure Biotech Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Weimin Miao - Innovator in qPCR Technology
Introduction
Weimin Miao is an inventor based in Changsha, China. He is currently associated with Sansure Biotech Inc. His work focuses on enhancing the performance of quantitative PCR (qPCR) tests, which are crucial in various fields, including medical diagnostics and research.
Latest Patent Applications
Weimin Miao has filed a patent application titled "COMPOSITION, REACTION LIQUID AND METHOD FOR IMPROVING QPCR TEST PERFORMANCE, AND USE THEREOF." This application describes a composition designed to improve the detection performance of fluorescent quantitative PCR. The composition includes bovine serum albumin, sorbitol, ammonium sulfate, formamide, tetramethylammonium chloride, and at least one of dithiothreitol and betaine. The invention aims to enhance the sensitivity, specificity, and interference resistance of real-time fluorescent quantitative PCR.
Conclusion
Weimin Miao's contributions to the field of qPCR technology demonstrate his commitment to advancing diagnostic methods. His innovative approaches have the potential to significantly improve the accuracy and reliability of PCR testing.